Suchergebnisse - "2494G1JF75"

PubPharm (928)

1

Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV

enthalten in: The Pediatric infectious disease journal | 2023

von Chabala, C. | Turkova, A. | Kapasa, M. | +113

2

Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2 : a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study

enthalten in: BMC pharmacology & toxicology | 2023

von Thoueille, P. | Delfraysse, M. | Andre, P. | +7

3

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children : A Substudy of the CHAPAS-4 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waalewijn, H. | Szubert, A. | Wasmann, R. | +18

4

Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings : a retrospective multicenter cohort study in China

enthalten in: Nature communications | 2023

von Wu, X. | Wu, G. | Ma, P. | +16

5

Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Abdizadeh, R. | Hadizadeh, F. | Abdizadeh, T.

6

Pharmacokinetics, Safety, and Bioequivalence of 2 Lopinavir/Ritonavir (200/50 mg) Tablets in Healthy Chinese Volunteers : Effect of Food on Absorption

enthalten in: Clinical pharmacology in drug development | 2023

von Zhang, W. | Lin, L. | Fu, W. | +5

7

Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus

enthalten in: The Cochrane database of systematic reviews | 2023

von Ugwu, E. | Eleje, G. | Ugwu, A. | +4

8

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

enthalten in: AIDS research and human retroviruses | 2023

von Leal, L. | Guardo, A. | Bedoya, L. | +10

9

Brief Report : Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Jacobs, T. | Mumbiro, V. | Chitsamatanga, M. | +48

10

Enterovirus D68 Infection Induces TDP-43 Cleavage, Aggregation, and Neurotoxicity

enthalten in: Journal of virology | 2023

von Zhang, L. | Yang, J. | Li, H. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[93]